메뉴 건너뛰기




Volumn 13, Issue 2, 2006, Pages 47-52

Long-acting risperidone therapy in patients hospitalized for psychotic disorders;Tratamiento con risperidona de liberación prolongada en pacientes hospitalizados por trastornos psicóticos

Author keywords

Adherence; Long acting risperidone; Schizophrenia

Indexed keywords

RISPERIDONE;

EID: 33745449059     PISSN: 11345934     EISSN: 15788962     Source Type: Journal    
DOI: 10.1016/s1134-5934(06)75338-6     Document Type: Article
Times cited : (2)

References (8)
  • 1
    • 0031916292 scopus 로고    scopus 로고
    • Compliance with medication regimens for mental and physical disorders
    • Cramer J, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49:196-201.
    • (1998) Psychiatr Serv , vol.49 , pp. 196-201
    • Cramer, J.1    Rosenheck, R.2
  • 2
    • 0033950999 scopus 로고    scopus 로고
    • Predicting medication noncompliance after hospital discharge among patients with schizophrenia
    • Olfson M, Mechanic D, Hansell S, et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000;51:216-22.
    • (2000) Psychiatr Serv , vol.51 , pp. 216-222
    • Olfson, M.1    Mechanic, D.2    Hansell, S.3
  • 3
    • 0041632398 scopus 로고    scopus 로고
    • Interventions to improve antipsychotic medication adherence: Review of recent literature
    • Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol. 2003;23:389-99.
    • (2003) J Clin Psychopharmacol , vol.23 , pp. 389-399
    • Dolder, C.R.1    Lacro, J.P.2    Leckband, S.3    Jeste, D.V.4
  • 4
    • 19244365937 scopus 로고    scopus 로고
    • A long-acting second generation anti-psychotic - Experience in Israel
    • Stein-Reisner O, Preisman O, Alfici S, Malamed Y, Bleich A. A long-acting second generation anti-psychotic - experience in Israel. Harefuah. 2004;143:408-9, 463.
    • (2004) Harefuah , vol.143 , pp. 408-409
    • Stein-Reisner, O.1    Preisman, O.2    Alfici, S.3    Malamed, Y.4    Bleich, A.5
  • 5
    • 0346515714 scopus 로고    scopus 로고
    • Stategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: Clinical studies
    • Kane JM. Stategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies. J Clin Psychiatry. 2003;64 Suppl 16:34-9.
    • (2003) J Clin Psychiatry , vol.64 , Issue.SUPPL. 16 , pp. 34-39
    • Kane, J.M.1
  • 6
    • 17344389726 scopus 로고    scopus 로고
    • The Expert Consensus Guideline Series. Optimizing pharmacological treatment of psychotic disorders
    • Kane JM, Leutch S, Carpenter D, Docherty JP, editors
    • Kane JM, Leutch S, Carpenter D, Docherty JP, editors. The Expert Consensus Guideline Series. Optimizing pharmacological treatment of psychotic disorders. J Clin Psychiatry. 2003;64 Suppl 12:xxxx.
    • (2003) J Clin Psychiatry , vol.64 , Issue.SUPPL. 12
  • 7
    • 0011814890 scopus 로고    scopus 로고
    • Patient satisfaction with their medication during long-term treatment with long-acting risperidone injection
    • Freyberger HJ, Eerdekens M, Duchesne I, et al. Patient satisfaction with their medication during long-term treatment with long-acting risperidone injection. Int J Neuropsychopharmacol. 2002;Suppl 1:189.
    • (2002) Int J Neuropsychopharmacol , vol.1 , pp. 189
    • Freyberger, H.J.1    Eerdekens, M.2    Duchesne, I.3
  • 8
    • 22244442155 scopus 로고    scopus 로고
    • Pharmacokinetic profile and clinical efficacy of long-acting risperidone: Potential benefits of combining an atypical antipsychotic and a new delivery system
    • Ereshefky L, Mannaert E. Pharmacokinetic profile and clinical efficacy of long-acting risperidone: potential benefits of combining an atypical antipsychotic and a new delivery system. Drugs R D. 2005;6:129-37.
    • (2005) Drugs R D , vol.6 , pp. 129-137
    • Ereshefky, L.1    Mannaert, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.